The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza.
Birnkrant
Debra
D
Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
Cox
Edward
E
D000146:Acids, Carbocyclic; D000998:Antiviral Agents / Q000627:therapeutic use*; D003517:Cyclopentanes / Q000627:therapeutic use*; D017277:Drug Approval; D015507:Drugs, Investigational / Q000627:therapeutic use*; D004630:Emergencies; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy*; D007275:Injections, Intravenous; D017387:Investigational New Drug Application; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D014481:United States; D014486:United States Food and Drug Administration
D000146:Acids, Carbocyclic; D000998:Antiviral Agents; D003517:Cyclopentanes; D015507:Drugs, Investigational; D004791:Enzyme Inhibitors; D006146:Guanidines; D009439:Neuraminidase; C414210:peramivir